NCT02808260View on ClinicalTrials.gov

Predicting Development of SCAF in Device Patients

RecruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

September 30, 2034

Study Completion Date

September 30, 2034

Conditions

Atrial Fibrillation

Trial Locations (1)

K1Y 4W7

RECRUITING

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors

collaborator

Genome Canada

OTHER

lead

Ottawa Heart Institute Research Corporation

OTHER